Nanobiotix

Identification
Instrument name
NANOBIOTIX
Symbol
NANO
ISIN code
FR0011341205
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
ICB
Biotechnology
Activity description

<p>
Nanobiotix develops nanoparticle-based technologies used in safe and non-invasive cancer treatments. Nanobiotix&rsquo;s technology, NanoXray, seeks to improve the efficacy of radiation therapy by limiting healthy tissues&rsquo; tolerance to the radiations that must pass through them to reach tumor tissues.<br />
<em>Source: Cofisem</em></p>

Website address
http://www.nanobiotix.com
Operation
IPO date
IPO type

<p>
Initial Public Offering</p>

IPO price
Indicative price range for the Offer: EUR 5.04 - EUR 6.16 (the "Offering Price")
IPO type
Initial Public offering
Catégorie
IPO
Operation calendar

<p>
23 October 2012 Listing date<br />
29 October 2012 First Trading date</p>